Keywords
Heart Failure
Cardiac Decompensation
Renal Insufficiency
Diagnosis
Epidemiology
How to Cite
Abstract
Background: Cardiorenal syndrome is defined as the coexistence of disorders between the heart and kidney in which alteration of one cause dysfunction of the other acutely or chronically.
Purpose: To determine the frequency of cardiorenal syndrome and the sociodemographic and clinical characteristics in hospitalized patients with heart failure.
Methodology: An observational, descriptive study was conducted that included patients with heart failure who were hospitalized between 2018 and 2021 from a hospital in Boyacá. Demographic, background, clinical and diagnostic variables were included for the evaluation and analysis of the information.
Results: A total of 347 patients were included. The frequency of cardiorenal syndrome was 10%, 20.17% were urban, 16.13% were male, 21.61% had arterial hypertension, 9.79% had diabetes mellitus and 8.64% had chronic obstructive pulmonary disease. Clinical characteristics: 12.10% had preserved heart failure, 10.08% had reduced heart failure, and 12.68% were Stevenson stage C, all with cardiorenal syndrome.
Conclusions: Cardiorenal syndrome is an affectation of multicausal origin, the clinical presentation depends on the organ causing the dysfunction, typically, patients with this clinical entity have had some decompensation that generates hospitalization admissions, changes in quality of life, worse prognosis, and mortality.
References
Junho CVC, Trentin-Sonoda M, Panico K, Dos Santos RSN, Abrahão MV, Vernier ICS, et al. Cardiorenal syndrome: long road between kidney and heart. Heart Fail Rev. 2022. http://dx.doi.org/10.1007/s10741-022-10218-w
Pereira-Rodríguez JE, Boada-Morales L, Niño-Serrato DR, Caballero-Chavarro M, Rincón-Gonzales G, Jaimes-Martín T, et al. Síndrome cardiorrenal. Rev colomb cardiol. 2017;24(6):602-13. https://doi.org/10.1016/j.rccar.2017.05.019
Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010;31(6):703-11. https://doi.org/10.1093/eurheartj/ehp507
Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, et al. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Can J Cardiol. 2017 nov.;33(11):1342-433. https://doi.org/10.1016/j.cjca.2017.08.022
Rozo-Ortiz EJ, Vargas LJ, Bautista-Moreno DG, Ortega-García SM, Valencia-Rincón LG, Hernández-Blanco LZ, et al. Síndrome cardiorrenal: enfoque diagnóstico, terapéutico y pronóstico. Med Int Méx. 2021;37(6):971-81. https://doi.org/10.24245/mim.v37i6.3562
Costanzo MR. The Cardiorenal Syndrome in Heart Failure. Cardiol Clin. 2022 my.;40(2):219-35. https://doi.org/10.1016/j.ccl.2021.12.010
Quiroga B, Santamaría Olomo R, Gorostidi M. Síndrome Cardiorrenal. Nefrología; 2020. https://www.nefrologiaaldia.org/es-articulo-sindrome-cardiorrenal-555
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021 sept. 21;42(36):3599-726. https://doi.org/10.1093/eurheartj/ehab368
Gorostidi M, Santamaría R, Alcázar R, Fernández-Fresnedo G, Galcerán JM, Goicoechea M, et al. Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease. Nefrología. 2014;34(3):302-16. https://doi.org/10.3265/Nefrologia.pre2014.Feb.12464
Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;99(1):34-47. https://doi.org/10.1016/j.kint.2020.10.012
Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. https://doi.org/10.1038/s41572-021-00284-z
Manzur Barbur MC, Mejía-Sanjuanelo AM, Anaya-Taboada M, García-Domínguez JC, Molano-Triviño A. English State of the art of cardiorenal syndrome, advantages and limitations of known therapies. Rev Colomb Nefrol. 2021 febr. 23;8(2):e517. https://doi.org/10.22265/acnef.8.2.517
Verma D, Firoz A, Garlapati SKP, Sai Charaan RST, Haris M, Dhungana B, et al. Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and Management. Cureus. 2021 ag. 17;13(8):e17240. https://doi.org/10.7759/cureus.17240
Chávez-Iñiguez JS, Sánchez-Villaseca SJ, García-Macías LA. Síndrome cardiorrenal: clasificación, fisiopatología, diagnóstico y tratamiento. Una revisión de las publicaciones médicas. Arch Cardiol Mex. 2022 abr. 4;92(2):253-63. https://doi.org/10.24875/ACM.20000183
Hatamizadeh P. Cardiorenal Syndrome: An Important Subject in Nephrocardiology. Cardiol Clin. 2021 ag.;39(3):455-69. https://doi.org/10.1016/j.ccl.2021.05.001
Bell SB, Ferrer HI, Monteagudo CA, Ferrer TI. Síndrome cardiorrenal. Arch Méd Camagüey. 2014;18(3):342-55. http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552014000300009&lng=es
House AA, Wanner C, Sarnak MJ, Piña IL, Mcintyre CW, Kasiske L, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. KDIGO Ex Concl. 2019;95(6):1304-17. https://doi.org/10.1016/j.kint.2019.02.022
Johansen KL, Chertow GM, Foley RN, Gilbertson DT, Herzog CA, Ishani A, et al. US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2021 abr.;77(4):A7-8. https://doi.org/10.1053/j.ajkd.2021.01.002
Kousa O, Mullane R, Aboeata A. Cardiorenal Syndrome. Florida, Estados Unidos: StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK542305/
Kumar U, Wettersten N, Garimella PS. Cardiorenal syndrome: Pathophysiology. Cardiol Clin. 2019;37(3):251-65. http://dx.doi.org/10.1016/j.ccl.2019.04.001
Wang J, Zhang W, Wu L, Mei Y, Cui S, Feng Z, et al. New insights into the pathophysiological mechanisms underlying cardiorenal syndrome. Aging. 2020;12(12):12422-31. http://dx.doi.org/10.18632/aging.103354
Yogasundaram H, Chappell MC, Braam B, Oudit GY. Cardiorenal syndrome and heart failure-challenges and opportunities. Can J Cardiol. 2019;35(9):1208-19. http://dx.doi.org/10.1016/j.cjca.2019.04.002
Alprecht-Quiroz P, Zúñiga-Pineda B, Lara-Terán JJ, Cáceres-Vinueza SV, Duarte-Vera YC. Síndrome cardiorrenal: aspectos clínicos y ecocardiográficos. Arch Cardiol Mex. 2020;90(4):503-10. https://doi.org/10.24875/ACM.20000087
Damman K, Valente AE, Voors AA, O'Connor MC, van DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis, Eur Heart J. 2014;35(7):455-69. https://doi.org/10.1093/eurheartj/eht386
Núñez J, Miñana G, Santas E, Bertomeu-González V. Síndrome cardiorrenal en la insuficiencia cardiaca aguda: revisando paradigmas. Rev Esp Cardiole. 2015;68(5):426-35. https://doi.org/10.1016/j.recesp.2014.10.016
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 abr. 16;139(16):e840-78. https://doi.org/10.1161/CIR.0000000000000664
Rodríguez-Espinosa D, Guzmán-Bofarull J, De La Fuente-Mancera JC, Maduell F, Broseta JJ, Farrero M. Multimodal Strategies for the Diagnosis and Management of Refractory Congestion. An Integrated Cardiorenal Approach. Front Physiol. 2022 jul. 8;13:913580. https://doi.org/10.3389/fphys.2022.913580
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.